Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

273 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Guideline for the management of clinically localized prostate cancer: 2007 update.
Thompson I, Thrasher JB, Aus G, Burnett AL, Canby-Hagino ED, Cookson MS, D'Amico AV, Dmochowski RR, Eton DT, Forman JD, Goldenberg SL, Hernandez J, Higano CS, Kraus SR, Moul JW, Tangen CM; AUA Prostate Cancer Clinical Guideline Update Panel. Thompson I, et al. Among authors: higano cs. J Urol. 2007 Jun;177(6):2106-31. doi: 10.1016/j.juro.2007.03.003. J Urol. 2007. PMID: 17509297 No abstract available.
Third international conference on innovations and challenges in prostate cancer: prevention, detection and treatment.
Carroll PR, Benaron DA, Blackledge G, Coakley FV, D'Amico AV, Higano CS, Iversen P, Kattan M, Nanus DM, Nelson JB, Oh WK, Roach M 3rd, Sellers WR, Smith MR, McMann MC, Kantoff PW. Carroll PR, et al. Among authors: higano cs. J Urol. 2003 Dec;170(6 Pt 2):S3-5. doi: 10.1097/01.ju.0000095101.18470.a0. J Urol. 2003. PMID: 14610403 Review. No abstract available.
Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes.
Cookson MS, Aus G, Burnett AL, Canby-Hagino ED, D'Amico AV, Dmochowski RR, Eton DT, Forman JD, Goldenberg SL, Hernandez J, Higano CS, Kraus SR, Moul JW, Tangen C, Thrasher JB, Thompson I. Cookson MS, et al. Among authors: higano cs. J Urol. 2007 Feb;177(2):540-5. doi: 10.1016/j.juro.2006.10.097. J Urol. 2007. PMID: 17222629 Review.
Erectile function outcome reporting after clinically localized prostate cancer treatment.
Burnett AL, Aus G, Canby-Hagino ED, Cookson MS, D'Amico AV, Dmochowski RR, Eton DT, Forman JD, Goldenberg SL, Hernandez J, Higano CS, Kraus S, Liebert M, Moul JW, Tangen C, Thrasher JB, Thompson I; American Urological Association Prostate Cancer Guideline Update Panel. Burnett AL, et al. Among authors: higano cs. J Urol. 2007 Aug;178(2):597-601. doi: 10.1016/j.juro.2007.03.140. Epub 2007 Jun 13. J Urol. 2007. PMID: 17570435 Review.
Estrogenic side effects of androgen deprivation therapy.
Guise TA, Oefelein MG, Eastham JA, Cookson MS, Higano CS, Smith MR. Guise TA, et al. Among authors: higano cs. Rev Urol. 2007 Fall;9(4):163-80. Rev Urol. 2007. PMID: 18231613 Free PMC article.
Treatment options for muscle-invasive urothelial cancer for patients who were not eligible for cystectomy or neoadjuvant chemotherapy with methotrexate, vinblastine, doxorubicin, and cisplatin: report of Southwest Oncology Group Trial 8733.
Higano CS, Tangen CM, Sakr WA, Faulkner J, Rivkin SE, Meyers FJ, Hussain M, Baker LH, Russell KJ, Crawford ED; Southwest Oncology Group Trial 8733. Higano CS, et al. Cancer. 2008 May 15;112(10):2181-7. doi: 10.1002/cncr.23420. Cancer. 2008. PMID: 18404692 Free PMC article.
Conventional treatments of localized prostate cancer.
Zerbib M, Zelefsky MJ, Higano CS, Carroll PR. Zerbib M, et al. Among authors: higano cs. Urology. 2008 Dec;72(6 Suppl):S25-35. doi: 10.1016/j.urology.2008.10.005. Urology. 2008. PMID: 19095125
Detection of previously unidentified metastatic disease as a leading cause of screening failure in a phase III trial of zibotentan versus placebo in patients with nonmetastatic, castration resistant prostate cancer.
Yu EY, Miller K, Nelson J, Gleave M, Fizazi K, Moul JW, Nathan FE, Higano CS. Yu EY, et al. Among authors: higano cs. J Urol. 2012 Jul;188(1):103-9. doi: 10.1016/j.juro.2012.03.008. Epub 2012 May 12. J Urol. 2012. PMID: 22583636 Free PMC article. Clinical Trial.
Improved overall survival trends of men with newly diagnosed M1 prostate cancer: a SWOG phase III trial experience (S8494, S8894 and S9346).
Tangen CM, Hussain MH, Higano CS, Eisenberger MA, Small EJ, Wilding G, Donnelly BJ, Schelhammer PF, Crawford ED, Vogelzang NJ, Powell IJ, Thompson IM Jr. Tangen CM, et al. Among authors: higano cs. J Urol. 2012 Oct;188(4):1164-9. doi: 10.1016/j.juro.2012.06.046. Epub 2012 Aug 22. J Urol. 2012. PMID: 22921015 Free PMC article.
273 results